Author | Edward A. Stadtmauer, MD

Articles

Tailoring Initial Treatment for Newly Diagnosed, Transplantation-Eligible Multiple Myeloma

March 15, 2010

ByEdward A. Stadtmauer, MD

High-dose melphalan (Alkeran) and autologous stem cell transplantation are commonly incorporated into the initial line of therapy for patients newly diagnosed with multiple myeloma.

Dose Intensity for Breast Cancer

June 01, 2001

ByEdward A. Stadtmauer, MD|Steven Stein, MD

Drs. Armstrong and Davidson have nicely reviewed the use of dose-intensive chemotherapy in the treatment of metastatic and high-risk early-stage breast cancer, and we agree with the basic premise of the article-that there are no conclusive data